For 80 years the Department of Psychiatry has provided the highest quality care to adults, children and adolescents, along with pioneering research and education.
Researchers from Mass General Brigham discovered that HBV does not cause liver inflammation or cancer on its own, but worsens liver inflammation and may make patients more susceptible to early cancer development caused by environmental carcinogens.
A Mass General Brigham study reveals how exercise rewires the brain at the cellular level, offering fresh insights into potential treatment strategies for Alzheimer’s disease.
Researchers, led by investigators from Allergy and Immunology at Mass General Brigham, have identified the mechanism underlying IgG antibody development to food proteins.
A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combining inavolisib with palbociclib and fulvestrant improves overall survival for patients with advanced PIK3CA-mutated breast cancer.
Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30-June 3 in Chicago.
1of
6
Innovation in Psychiatry
Neuroscience Advances in Motion is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in psychiatry, neurology and neurosurgery.